Pag-aaral pangklinika para sa COPD sa Indiana
11 pag-aaral para sa COPD ang naghahanap ng mga kalahok sa mga site sa Indiana.
Mga Lungsod sa Indiana
Opisyal na teksto ng pag-aaral (English)
Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)
- Velocity Clinical Research ( Site 4464), Valparaiso
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07874815A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Indiana University Health University Hospital, Indianapolis
- IU Health Ball Memorial Hospital, Inc., Muncie
Nagre-recruitPhase 2
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07759245To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- DM Clinical Research-Indianapolis, Indianapolis
Nagre-recruitPhase 2
Edad 40 hanggang 85 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07684820Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Asha Clinical Research - Munster- Site Number : 8400115, Hammond
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07190222A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- ASHA Clinical Research - Munster, LLC, Hammond
- Methodist Hospital Southlake, Merrillville
Nagre-recruitPhase 2/3
Edad 35 hanggang 80 · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07363694Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Indy Clinical Research- Site Number : 8400071, Indianapolis
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07190209The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- IU Health Pulmonology & Critical Care Medicine, Indianapolis
Nagre-recruitObservasyonal na pag-aaral
Edad 40 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT07612878A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Evansville
- Research Site, Indianapolis
- Research Site, Indianapolis
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT06878261Acoustic Waveform Respiratory Evaluation
- Indiana University, Indianapolis
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 8 hanggang 70 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06512064A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Valparaiso
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06283966A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Munster
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06883305Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.